What factors drove the changes in Sun Life Financial's revenue and profit?

Did Sun Life Financial beat or miss consensus estimates last quarter?

What is the market's earnings forecast for Sun Life Financial next quarter?

What were the key takeaways from Sun Life Financial’s earnings call?

What does Sun Life Financial do and what are its main business segments?

What were the key takeaways from Sun Life Financial's earnings call?

What guidance did Sun Life Financial's management provide for the next earnings period?

What is Sun Life Financial's latest dividend and current dividend yield?

- **Record Q4 Earnings**: CAD 1.1B net income, 17% EPS growth, 19.1% ROE.
- **Asset Management Strength**: SLC exceeds target, MFS AUM up 8% to CAD 651B.
- **Protection Sales Surge**: 50% YoY growth, Hong Kong up 111%, U.S. Stop-Loss sales +58%.
- **Capital Discipline**: 157% LICAT ratio, CAD 3.7B returned to shareholders.
- **Strategic Moves**: SLC management equity plan, BGO/Crescent buyouts, digital transformation.
- **U.S. Stop-Loss Dominance**: 17% rate increase, 58% sales growth, loss ratio stabilization.
- **Dental Progress**: Medicaid loss ratio down to 88.8%, commercial growth at 7%.


**【CEO Summary Section】**
- Delivered Q4 underlying net income of CAD 1.1 billion, up 13% YoY, with EPS growth of 17% and ROE of 19.1%. 
- Asset management and wealth businesses showed strong performance: SLC Management exceeded 2025 target with CAD 242M in net income, and MFS saw CAD 651B in AUM.
- Protection sales grew 50% YoY, driven by Hong Kong (111% growth) and Indonesia (43% growth). 
- U.S. Medical Stop-Loss sales rose 58% YoY, with a 17% rate increase reflecting pricing discipline.
- LICAT ratio of 157% highlights strong capital position.

**【CFO Financial Commentary】**
- Full-year underlying EPS growth of 12%, exceeding 10% medium-term target.
- Generated CAD 4.2B in organic capital, returning CAD 3.7B to shareholders via dividends and buybacks.
- Completed buyouts of BGO and Crescent, with management equity plan allowing employees to own up to 25% of SLC.
- Corporate segment expects CAD 110-120M quarterly loss,不影响整体目标.
- MFS saw CAD 651B AUM, up 8% YoY, despite retail outflows due to passive index preference.

**【Q&A Key Highlights】**
- **Stop-Loss Business**: 58% YoY sales growth, 17% rate increase, loss ratio stabilization at 74%. Hard market benefits scale and underwriting.
- **Dental Business**: Medicaid loss ratio improved to 88.8% (from 94.2%), but ongoing cost challenges. Commercial premium growth at 7%.
- **Asset Management**: SLC fee-related earnings up 25% YoY, targeting 20% growth. MFS AUM up 8% YoY, cash flow support for core business.
- **Capital Deployment**: LICAT ratio at 157%, buybacks to resume post-private asset buyouts. Focus on organic growth and bolt-on M&A.
- **Asia Growth**: Hong Kong sales up 111%, Indonesia partnerships driving expansion. New business CSM up 44% YoY.


Sun Life Financial Inc. (SLF) Q4 2025 Earnings Call Transcript

- **EPS Growth Strong**: Underlying EPS up 6% YoY, ROE near medium-term target.
- **US Dental Risk**: 2025 loss ratio +1.5pts Q3, 2026 repricing +14% YoY.
- **Asset Management Resilience**: MFS net outflows lowest since 2021, SLC on track for $235M growth.
- **Asia Outperformance**: Protection sales +38% YoY, CSM +17% YoY.
- **Capital Discipline**: 60% organic capital generation, $400M buybacks Q3.

**【CEO Opening Remarks】**
- Underlying EPS of $1.86, up 6% YoY, driven by strong sales in Asia and Canada.
- ROE of 18.3%, progressing toward medium-term target of 20%.
- Individual protection sales grew 35% YoY, group health 12%, and asset management saw $3B net inflows.
- US business underperformed due to higher claims frequency in stop loss and dental.

**【CFO Financial Commentary】**
- GAAP net income: $1.047B (3% YoY), Non-GAAP EPS: $1.86 (6% YoY).
- Asset management AUM: $1.6T, with MFS net outflows of $0.9B (lowest since 2021).
- SLC Management on track for $235M YoY growth, MFS margin: 39.2%.
- LICAT ratio: 154%, up 3pts QoQ, supporting $400M share buybacks.

**【Q&A Highlights】**
- **US Dental Challenges**: 2026 repricing expected to offset 7% YoY utilization growth. 2025 cohort loss ratio updated +1.5pts Q3.
- **Asset Management Momentum**: MFS wins $12.9B institutional mandates, SLC deploys $7.4B.
- **Dividend Policy**: Organic capital generation (60% of net income) supports 40-50% payout ratio.
- **Asia Growth**: Individual protection sales up 38% YoY, CSM +17% YoY.
- **US Stop Loss Volatility**: Q4 claims expected to reflect 30% of 2025 cohort, with 2026 pricing +14% YoY.


Sun Life Financial Inc (SLF) Q3 2025 Earnings Call Transcript

- **Strong Financial Performance**: Underlying EPS up 4% YoY, with record U.S. Employee Benefits earnings and robust growth in Asia.
- **U.S. Dental Challenges**: Near-term Medicaid funding uncertainty reforecasted 2025 earnings, but long-term commercial growth strategy remains intact.
- **Digital Innovation**: Generative AI and mobile app enhancements drive client engagement and efficiency across regions.
- **Capital Strength**: SLF LICAT ratio of 151% supports $400 million in share buybacks and strategic investments.
- **Asia Leadership**: Record $206 million in net income, with 22% YoY sales growth in Individual Protection and 67% growth in Asset Management.

**【CEO Summary Section】**
- Underlying EPS of $1.79, up 4% YoY, driven by strong performance across all regions.
- U.S. Employee Benefits business achieved record earnings, while U.S. Dental business faced challenges due to Medicaid funding uncertainty.
- Digital initiatives, such as generative AI tools and mobile app enhancements, are driving client engagement and operational efficiency.
- Leadership transition announced for U.S. business, with David Healy succeeding Dan Fishbein in September 2026.

**【CFO Financial Commentary】**
- Underlying net income of $1.015 billion (up 2% YoY), with asset management and wealth businesses contributing $635 billion in AUM.
- U.S. Dental business reported lower-than-expected earnings due to Medicaid claims volatility, with a reforecasted trajectory for 2025.
- SLC Management delivered $6 billion in capital raising, up 100% YoY, despite quarterly volatility in seed investments.
- Capital position remains strong, with an SLF LICAT ratio of 151% and $400 million in share buybacks during the quarter.

**【Q&A Highlights】**
- **U.S. Dental Business**: Near-term challenges include Medicaid funding uncertainty, but long-term growth expected through commercial expansion and repricing. 2025 earnings target of $100 million is no longer achievable, with a focus on 1/3 of U.S. earnings growth from Dental by 2029.
- **MFS Outflows**: $14.3 billion in net outflows driven by market volatility, but gross sales up YoY, signaling client confidence. Margins impacted by lower AUM but expected to recover in Q3/Q4.
- **SLC Management**: Fee-related earnings up 37% YoY, with $6 billion in capital raising. Seed investment volatility caused quarterly fluctuations, but medium-term growth targets remain on track.
- **Asia Growth**: Record $206 million in underlying net income, driven by 22% YoY sales growth in Individual Protection and 67% growth in Asset Management and Wealth businesses.
- **Digital Transformation**: Investments in generative AI, mobile apps, and real-time underwriting are enhancing client experience and operational efficiency across regions.

Sun Life Financial Inc. (SLF) Q2 2025 Earnings Call Transcript

- **Q1 Growth Drivers**: Underlying EPS up 21% YoY, fueled by AM&W fee income, GHP large case sales, and Asia IP growth (India +35%, Hong Kong agency +30%).
- **Capital Strength**: $520M share buybacks and 149% LICAT ratio highlight financial resilience, supporting $10M NCIB renewal.
- **U.S. Business Stabilization**: Stop-loss claims in line with expectations, Dental restructured pricing reduces volatility, but U.S. Dental sales down 13% YoY.
- **SLC Outperformance**: Fee-related earnings up 43% YoY, driven by BGO Asia catch-up fees and private credit deployments, with $235M 2025 target on track.
- **MFS Long-Term Focus**: 92% of fund assets rank top half by Morningstar, offsetting retail outflows with institutional inflows and active ETF growth.

**【CEO Opening Remarks】**
- Q1 2025 underlying EPS of $1.82, up 21% YoY, driven by strong performance across all business segments.
- Asset Management & Wealth (AM&W) saw fee income growth and seed investment gains, with SLC Management raising $4.4B in Q1.
- Group Health & Protection (GHP) earnings up 18% YoY, supported by Canada's large case sales and improved U.S. stop-loss results.
- Individual Protection (IP) sales growth across Asia, with India leading at 35% YoY, and Hong Kong agency productivity gains.
- Capital strength maintained with LICAT ratio at 149% and $1.3B holdco cash, enabling $520M share buybacks.

**【CFO Financial Highlights】**
- Record underlying net income of $1.045B, up 19% YoY, with AM&W and GHP contributing 19% and 18% growth, respectively.
- MFS reported $186M underlying net income, down 2% YoY due to retail outflows, but 92% of fund assets ranked top half by Morningstar over 10 years.
- SLC Management fee-related earnings up 43% YoY to $99M, driven by BGO Asia catch-up fees and private credit deployments.
- Canada delivered $376M underlying net income, up 21% YoY, with Group Retirement Services (GRS) and SLGI mutual fund sales growth.
- U.S. underlying net income of $151M, up 7% YoY, with Dental stabilization and stop-loss claims in line with expectations.
- Asia recorded $197M underlying net income, up 11% YoY, with Hong Kong CSM growth and India AUM expansion.

**【Q&A Key Themes】**
- **Asia Sales Momentum**: Manjit Singh highlighted 17% YoY IP sales growth across 6-8 markets, driven by agency, bancassurance, and broker channels. Hong Kong CSM growth and India AUM expansion offset macro uncertainties.
- **U.S. Volatility**: Dan Fishbein noted stop-loss stabilization in Q1 but acknowledged seasonal variability. Dental restructured pricing and Medicaid retroactive payments supported margins, though U.S. Dental sales declined 13% YoY.
- **Capital Allocation**: Tim Deacon renewed NCIB for up to 10M shares, balancing buybacks with $2.3B SLC minority buy-up. Holdco cash at $1.3B supported financial flexibility amid macro risks.
- **SLC Growth**: Steve Peacher reaffirmed $235M 2025 target, citing fee-earning AUM growth and BGO Asia deployments. Catch-up fees and seed investments drove Q1 surges, but warned of quarterly variability.
- **MFS Strategy**: Ted Maloney emphasized long-term performance, with 98% of fixed income assets in top Morningstar quartiles. Active ETFs and international equity mandates offset retail outflows.


Sun Life Financial, Inc. (SLF) Q1 2025 Earnings Call Transcript

- **U.S. Stop-Loss Challenges**: Q4 loss ratio 74% vs. target 73%, driven by industry-wide severity. 14% price hike for 2025, with additional 2% needed.
- **Asset Management Strength**: MFS fee income +13% YoY; SLC Management raises $10.2B in Q4.
- **Asia Growth**: Underlying net income +20% YoY, CSM up 30% YoY.
- **Capital Management**: $350M organic capital generation; LICAT ratio stable at 152%.
- **Dental Recovery**: 2025 target of $100M earnings; 2024 impacted by one-time $12M provision.

**【CEO Opening Remarks】**
- **Positive Performances**: Canada, Asia, and Asset Management drove Q4 underlying earnings, offsetting U.S. challenges from higher stop-loss claim severity. U.S. stop-loss claims severity was industry-wide, with Q4 loss ratio at 74% vs. priced target of 73%.
- **Capital Strength**: LICAT ratio of 152% at SLF, supporting $3 million shares repurchased under NCIB.
- **Strategic Momentum**: Group sales growth in Canada and U.S., with Dental business stabilizing through repricing and claims management.

**【CFO Financial Breakdown】**
- **Q4 Results**: Underlying net income $965M (-2% YoY), driven by U.S. stop-loss and Canada morbidity. Full-year underlying EPS up 5% at $6.66.
- **Key Business Units**:
  - **Asset Management**: MFS fee income up 13% YoY; SLC Management raised $10.2B in Q4, record net flows $14.1B.
  - **Canada**: Wealth AUM up 13% YoY; Group Benefits revenue +11% YoY.
  - **U.S.**: Stop-loss loss ratio 74%, Dental business improving with Medicaid repricing.
  - **Asia**: Underlying net income +20% YoY, CSM growth 30% YoY.
- **One-Time Items**: $234M tax loss from USD/CAD volatility; $12M Vietnam bancassurance impairment.
- **Capital Generation**: $350M organic capital (36% of underlying net income), supporting buybacks and growth.

**【Q&A Highlights】**
- **Stop-Loss Outlook**: 14% price increase for 2025, additional 2% needed to offset severity. 2025 loss ratio expected to improve with pricing, but some pressure may persist.
- **Tax Volatility**: Actions to mitigate USD/CAD impact; expect lower volatility but modest higher effective tax rate.
- **Asset Management**: MFS fixed income net inflows $1.5B; SLC deployments $6.3B, up sequentially.
- **Vietnam Bancassurance**: Regulatory changes affecting commission structures; impairment reflects industry-wide decline.
- **Dental Business**: 2025 target of $100M underlying earnings; 2024 results impacted by one-time provision.
- **Capital Allocation**: Prioritize buybacks with strong organic generation and LICAT stability.

Actual												0.9204	0.9251	1.078	1.1538	1.1537	1.2113	1.2138	1.2096	1.1508	1.1802	1.1706	1.2467	1.1239	1.1844	1.1704	1.2676	1.1073	1.2568	1.3007	1.1674	1.2646	1.3148	1.3355	1.431
Forecast												0.7841	0.8076	0.9541	1.0872	1.1617	1.186	1.195	1.198	1.1274	1.0718	1.0623	1.1328	1.1148	1.157	1.1664	1.1893	1.2201	1.1543	1.2545	1.2312	1.1839	1.3003	1.3116	1.3613
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+17.38%	+14.55%	+12.99%	+6.13%	-0.69%	+2.13%	+1.57%	+0.97%	+2.08%	+10.11%	+10.19%	+10.05%	+0.82%	+2.37%	+0.34%	+6.58%	-9.25%	+8.88%	+3.68%	-5.18%	+6.82%	+1.12%	+1.82%	+5.12%

Actual	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	716.87M	1.04B	976.10M
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	1.11B	--	--	--	--	--	944.53M	973.53M
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+10.00%	+0.26%

SLF

SLF fundamentals

SLF Q4 2025 Earnings

Earnings Call

You can ask Aime

SLF

SLF fundamentals

SLF Q4 2025 Earnings

Earnings Call

SLF Earnings Call Summary for Q4/202511:00 AM on Feb 12, 2026

SLF Earnings Call Summary for Q3/202510:00 AM on Nov 6, 2025

SLF Earnings Call Summary for Q2/202510:00 AM on Aug 8, 2025

SLF Earnings Call Summary for Q1/202510:00 AM on May 9, 2025

SLF Earnings Call Summary for Q4/202410:00 AM on Feb 13, 2025

You can ask Aime